MSHL, Marshall Edwards Inc.

** MSHL reported that the U.S. Patent and Trademark Office has issued a new patent, U.S. Patent No. 8,080,675, covering a number of the Company's isoflavone-based compounds, including lead oncology-drug candidates ME-143 and ME-344, and their pharmaceutical compositions. The patent is estimated to provide protection until March 2027.

VPF, Valpey Fisher Corp.

** CTS Corporation and VPF reported that they have entered into a definitive merger agreement providing for the cash acquisition of VPF by CTS. Upon closing of the transaction, VPF will operate as an indirect wholly-owned subsidiary of CTS.

To view video, and read the full article visit URL http://crweselect.com/27275/stock-alerts/slxp-cpts-clno-nrci-valv-crwese...

Salix Pharmaceuticals Ltd. (NASDAQ:SLXP)

SLXP, Salix Pharmaceuticals, Ltd.

** On its third quarter fiscal 2011 results, SLXP posted total product revenue of $146.2 million, an 81% increase year over year.

SLXP is increasing its estimate of 2011 total product revenue to approximately $535 million, which represents 59% growth over 2010 revenue.